KEVIN SERRANO: Open Payments
NPI 1255962445 · NAPERVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,162 in 203 payments from 21 companies in 2025. Trend: 2023 $2,225 · 2024 $4,299 · 2025 $4,162
Food & beverage: $4,046Education: $116
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 15 | $534 |
| ABBVIE INC. | 23 | $379 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $317 |
| Axsome Therapeutics, Inc. | 9 | $314 |
| Corium, LLC | 22 | $287 |
| Collegium Pharmaceutical, Inc. | 14 | $285 |
| Teva Pharmaceuticals USA, Inc. | 12 | $263 |
| Otsuka America Pharmaceutical, Inc. | 14 | $259 |
| Lundbeck LLC | 11 | $218 |
| Neurocrine BioSciences, Inc. | 11 | $208 |
Products named: FANAPT, REXULTI, VRAYLAR, CAPLYTA, Auvelity, Azstarys, Jornay PM, INGREZZA.
Industry payments across IL — which companies pay providers there.
